| Trial ID: | L6513 |
| Source ID: | NCT00490178
|
| Associated Drug: |
Fenofibrate 80 Mg And Metformin 1000 Mg (Fixed Combination)
|
| Title: |
Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Dyslipidemia
|
| Interventions: |
DRUG: Fenofibrate 80 mg and metformin 1000 mg (fixed combination)
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Solvay Pharmaceuticals
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
29
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-03
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2007-09-03
|
| Locations: |
Site 3, Marseille, France|Site 1, Nantes, France|Site 2, Tours, France
|
| URL: |
https://clinicaltrials.gov/show/NCT00490178
|
